R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25
{{output}}
In this update, we discuss the use of real-world data in the Haute Autorité de Santé assessment of economic evaluations, review how real-world evidence is supporting regulatory approvals in multiple myeloma, and consider lessons from the failed EVOKE trials ... ...
